Cited by 43MicroRNA in disease regulationNeurogenesis and neuroplasticity mechanismsNeuroinflammation and Neurodegeneration Mechanisms

MicroRNA‑124: an emerging therapeutic target in central nervous system disorders

Open access
Zhang, Wen-Hao, Jiang, Lian, Li, Mei, Liu, Jing·2023·Experimental Brain Research

Abstract

The central nervous system (CNS) consists of neuron and non-neuron cells including neural stem/precursor cells (NSPCs), neuroblasts, glia cells (mainly astrocyte, oligodendroglia and microglia), which thereby form a precise and complicated network and exert diverse functions through interactions of numerous bioactive ingredients. MicroRNAs (miRNAs), with small size approximately ~ 21nt and as well-documented post-transcriptional key regulators of gene expression, are a cluster of evolutionarily conserved endogenous non-coding RNAs. More than 2000 different miRNAs has been discovered till now. MicroRNA-124(miR-124), the most brain-rich microRNA, has been validated to possess important functions in the central nervous system, including neural stem cell proliferation and differentiation, cell fate determination, neuron migration, synapse plasticity and cognition, cell apoptosis etc. According to recent studies, herein, we provide a review of this conversant miR-124 to further understand the potential functions and therapeutic and clinical value in brain diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00221-022-06524-2

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent therapeutic approaches involving the delivery of miRNA-124 have demonstrated a neuroprotective role, showing promise in treating neurodegenerative disorders and brain traumas.

    “Recent therapeutic approaches involving the delivery of miRNA-124 have demonstrated a neuroprotective role, showing promise in treating neurodegenerative disorders and brain traumas [167, 168].”

    From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [168]

    The section on degenerative diseases reports that injected miR-124 nanoparticles may improve outcomes in Parkinson’s disease model mice. The ischemia–reperfusion section reports neuroprotective effects from increased miR-124, but also describes conflicting results; its exosome-delivery example reports increased neurogenesis without establishing an effect on neuronal death or infarct size. The copy does not substantiate the claimed benefit of miR-124 delivery for brain trauma. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

1 of the 111 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Zhang, W.-H., Jiang, L., Li, M., & Liu, J.
Affiliations
  • Hebei Medical University (CN)
  • Chinese PLA General Hospital (CN)
Corresponding author
Liu, Jing
Venue
Experimental Brain Research
Published
2023-03-24
Volume
241
Issue
5
Pages
1215-1226
ISSN
  • 0014-4819 (ISSN-L)
  • 1432-1106
OpenAlex
W4360810232
Cited by
43
References
111
Citations by year
2026: 13 · 2025: 14 · 2024: 15 · 2023: 1
FWCI
1.36
Type
journal article
Language
en
Open access
Locations
  • Experimental Brain Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
national natural science foundation of china (No. 81471087)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
miR-124, microRNA, central nervous system disorders, post-transcriptional regulation, neuronal migration, synaptic plasticity, cognitive function, apoptosis, therapeutic target, brain disorders
MeSH terms
Cell Differentiation, Central Nervous System, Central Nervous System Diseases, Humans, Neuroglia, MicroRNAs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review